some more press from proactive investors -Broker places $1.15 price target on Resource Generationhttp://www.proactiveinvestors.com.au/companies/news/5991/broker-places-115-price-target-on-resource-generation-5991.html
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%